CSIMarket Company Name, Ticker, Suppliers, else..
 
Axim Biotechnologies Inc   (AXIM)
 
Price: $0.0040 $0.00 0.000%
Day's High: $0.004000000189989805 Week Perf: 33.33 %
Day's Low: $ 0.00 30 Day Perf: 33.33 %
Volume (M): 176,300 52 Wk High: $ 0.03
Volume (M$): $ 0 52 Wk Avg: $0.01
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 291
 Employees 45
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Axim Biotechnologies Inc is a biotechnology company that specializes in the development of pharmaceutical and nutraceutical products. The company focuses on utilizing cannabinoid compounds for various medicinal purposes. Axim Biotechnologies conducts research, development, and clinical trials to create innovative therapies and treatments for conditions such as multiple sclerosis, irritable bowel syndrome, psoriasis, and opioid addiction. The company's goal is to provide safe and effective solutions for patients through the use of cannabinoids.


   Company Address: 6191 Cornerstone Court San Diego 92121 CA
   Company Phone Number: 923-4422   Stock Exchange / Ticker: AXIM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
GBLX        33.33% 
IIPR        0.67% 
TLRY   -0.88%    
• View Complete Report
   



Product Service News

Pioneering Diagnostic Research Programs in Dry Eye Disease and Parkinson's Disease: Axim Biotechnologies Steers Ahead

Published Wed, Mar 27 2024 1:01 PM UTC

In the fast-paced and ever-evolving field of healthcare, biotech companies are continually striving to innovate and improve patient outcomes. Axim Biotechnologies, a ground-breaking pharmaceutical company, has recently presented groundbreaking research and development initiatives at the Benzinga Virtual Healthcare Summit 2024. This article aims to interpret the key findings ...
Partnership

Scaling Up Diagnostic Tools: AXIM Biotechnologies Joins Hands with Auer Precision to Amplify Assay Production

Published Wed, Dec 20 2023 2:00 PM UTC

Biotech company AXIM Biotechnologies has entered into a critical partnership with a leading diagnostic manufacturer, Auer Precision, to scale up the production of diagnostic assays for testing Immunoglobulin E (IgE) and Lactoferrin DED, marking a significant milestone in the evolution of the diagnostic healthcare industry.AXIM Biotechnologies, fervently dedicated to amplifyi...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 12.58
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0
Working Capital Ratio 0
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.02 $
Revenues (TTM) 0 $
Cash Flow (TTM) -
Cash 0 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 2,059
Net Income per Employee (TTM) -91,908
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.02

Profitability Ratios Current
Gross Margin (MRQ) 90.02 %
Operating Margin (MRQ) -3257.86 %
Net Margin (MRQ) -12985.95 %
Net Cash Flow Margin (MRQ) -518.72 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.